Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1201 to 1215 of 1260 results for heart OR cardi* OR arrythmia

  1. NHS urged to tackle antibiotic resistance

    The NHS is being urged to tackle the rise in antibiotic resistance by cutting back on unnecessary use of the drugs.

  2. NICE announces Dr Samantha Roberts as new Chief Executive

    NICE Chairman, Sharmila Nebhrajani, today announced Dr Samantha Roberts as incoming Chief Executive.

  3. New recommended drinking guidelines welcomed by NICE

    NICE has welcomed proposed new guidelines on alcohol which aim to limit the health risks that result from drinking.

  4. NICE approves ground-breaking cholesterol-lowering drug inclisiran

    NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke.

  5. NICE approves new treatment for stroke prevention

    Patients with atrial fibrillation can now be offered rivaroxaban (Xarelto), as an alternative to warfarin, in order to reduce their risk of stroke and blood clots, says NICE.

  6. NICE calls on local government to boost physical activity

    Local government can improve the health and wellbeing of their communities, and save money in the long-term, by encouraging people to be more physically active, says NICE.

  7. NICE chief executive and chairman thank non-executive director for his service as he announces resignation

    Professor Martin Cowie stands down from the NICE board following his appointment to a role at Astra Zeneca

  8. NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

    Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.

  9. NICE does not recommend elusulfase alfa for NHS use following evaluation of new evidence

    NICE has today (12 November 2021) published draft guidance for public consultation which does not recommend elosulfase alfa (also called Vimizin and made by BioMarin) for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).

  10. Annual diabetes checks among indicators proposed for latest NICE QOF menu

    A series of annual checks to monitor and improve the health of people with diabetes are among measures proposed by NICE for its latest Quality and Outcomes Framework (QOF) indicator menu.

  11. Education classes essential for adults with diabetes, says NICE

    Adults with type 1 diabetes should be offered education classes to help them manage their condition, a new quality standard from NICE says.

  12. Children and young people need accurate, accessible information about their healthcare

    New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.

  13. Call for abstracts for HTAi 2021 Annual Meeting in Manchester

    Health Technology Assessment International (HTAi) has released the plenary themes for the HTAi 2021 Annual Meeting and opened their call for abstract submissions

  14. Children and young people with suspected diabetes should be seen by a specialist immediately, says NICE quality standard

    When a GP suspects a child or young person has diabetes, they should immediately be sent to hospital and seen the same day by a specialist, a new NICE quality standard says.

  15. Age 'should not be barrier to treatment'

    Decisions around whether to offer a person surgical treatment should not be based on age and fitness, according to a new report.